147 related articles for article (PubMed ID: 37357760)
1. Role and mechanism of leukemia inhibitory factor receptor in cervical cancer invasion and metastasis.
Hu H; Zhao Q; Sang Y; Xiao Y; Jiang N
J Int Med Res; 2023 Jun; 51(6):3000605231182557. PubMed ID: 37357760
[TBL] [Abstract][Full Text] [Related]
2. Leukemia inhibitory factor promotes gastric cancer cell proliferation, migration, and invasion via the LIFR-Hippo-YAP pathway.
Bian SB; Yang Y; Liang WQ; Zhang KC; Chen L; Zhang ZT
Ann N Y Acad Sci; 2021 Jan; 1484(1):74-89. PubMed ID: 32827446
[TBL] [Abstract][Full Text] [Related]
3. LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker.
Chen D; Sun Y; Wei Y; Zhang P; Rezaeian AH; Teruya-Feldstein J; Gupta S; Liang H; Lin HK; Hung MC; Ma L
Nat Med; 2012 Oct; 18(10):1511-7. PubMed ID: 23001183
[TBL] [Abstract][Full Text] [Related]
4. [FABP5 promotes cell growth, invasion and metastasis in cervical cancer].
Zhan YZ; Liu F; Zhang Y; Mo XY; Cheng WD; Wang W
Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):200-207. PubMed ID: 30917456
[No Abstract] [Full Text] [Related]
5. Leukemia Inhibitory Factor Receptor Suppresses the Metastasis of Clear Cell Renal Cell Carcinoma Through Negative Regulation of the Yes-Associated Protein.
Lei C; Lv S; Wang H; Liu C; Zhai Q; Wang S; Cai G; Lu D; Sun Z; Wei Q
DNA Cell Biol; 2018 Aug; 37(8):659-669. PubMed ID: 29902078
[TBL] [Abstract][Full Text] [Related]
6. Circ_0003159 upregulates LIFR expression through competitively binding to miR-221-3p/miR-222-3p to block gastric cancer development.
Zheng L; Yan B; Jin G; Han W; Wang H; Wang Z; Ma Y; Nian Y; Meng X; Jiang Z
J Mol Histol; 2022 Apr; 53(2):173-186. PubMed ID: 35034206
[TBL] [Abstract][Full Text] [Related]
7. TRIP6 accelerates the proliferation and invasion of cervical cancer by upregulating oncogenic YAP signaling.
Yang F; Li L; Zhang J; Zhang J; Yang L
Exp Cell Res; 2020 Nov; 396(1):112248. PubMed ID: 32853630
[TBL] [Abstract][Full Text] [Related]
8. Pro-invasive activity of the Hippo pathway effectors YAP and TAZ in cutaneous melanoma.
Nallet-Staub F; Marsaud V; Li L; Gilbert C; Dodier S; Bataille V; Sudol M; Herlyn M; Mauviel A
J Invest Dermatol; 2014 Jan; 134(1):123-132. PubMed ID: 23897276
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of shRNA targeting GPR48 on invasion and metastasis of human cervical carcinoma cell line HeLa.
Gao Y; Shan ZY; Wang H; Zhang HM; Teng WP
Ai Zheng; 2009 Feb; 28(2):104-7. PubMed ID: 19550120
[TBL] [Abstract][Full Text] [Related]
10. MPDZ as a novel epigenetic silenced tumor suppressor inhibits growth and progression of lung cancer through the Hippo-YAP pathway.
Liu W; Huang Y; Wang D; Han F; Chen H; Chen J; Jiang X; Cao J; Liu J
Oncogene; 2021 Jul; 40(26):4468-4485. PubMed ID: 34108620
[TBL] [Abstract][Full Text] [Related]
11. Hsa_circ_0001073 targets miR-626/LIFR axis to inhibit lung cancer progression.
Liu Q; Cao G; Wan Y; Xu C; He Y; Li G
Environ Toxicol; 2021 Jun; 36(6):1052-1060. PubMed ID: 33475233
[TBL] [Abstract][Full Text] [Related]
12. Leukemia inhibitory factor receptor negatively regulates the metastasis of pancreatic cancer cells in vitro and in vivo.
Ma D; Jing X; Shen B; Liu X; Cheng X; Wang B; Fu Z; Peng C; Qiu W
Oncol Rep; 2016 Aug; 36(2):827-36. PubMed ID: 27375070
[TBL] [Abstract][Full Text] [Related]
13. YAP-Hippo signalling downstream of leukemia inhibitory factor receptor: implications for breast cancer.
Hergovich A
Breast Cancer Res; 2012 Dec; 14(6):326. PubMed ID: 23216692
[TBL] [Abstract][Full Text] [Related]
14. Mutant KRAS Downregulates the Receptor for Leukemia Inhibitory Factor (LIF) to Enhance a Signature of Glycolysis in Pancreatic Cancer and Lung Cancer.
Liu S; Gandler HI; Tošić I; Ye DQ; Giaccone ZT; Frank DA
Mol Cancer Res; 2021 Aug; 19(8):1283-1295. PubMed ID: 33931487
[TBL] [Abstract][Full Text] [Related]
15. miR-221-3p regulates hepatocellular carcinoma cell proliferation, migration and invasion via targeting LIFR.
Tan W; Li Z; Xia W; Zhu J; Fan R
Ann Hepatol; 2022 Jan; 27 Suppl 1():100567. PubMed ID: 34699986
[TBL] [Abstract][Full Text] [Related]
16. [Bcl-2 associated athanogene 3 affects the epithelial-mesenchymal transition in human cervical cancer].
Wei L; Qin XP; Zhao XX; Wang W
Zhonghua Fu Chan Ke Za Zhi; 2017 Aug; 52(8):551-557. PubMed ID: 28851173
[No Abstract] [Full Text] [Related]
17. [Relationship between MTA1 expression and invasive and metastatic ability of cervical cancer cell].
Han XY; Qian HL; Yang JJ; Zhang XY; Fu M; Liang X; Lin C; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):678-83. PubMed ID: 22176993
[TBL] [Abstract][Full Text] [Related]
18. Lidocaine Suppresses Gastric Cancer Development Through Circ_ANO5/miR-21-5p/LIFR Axis.
Guan E; Liu H; Xu N
Dig Dis Sci; 2022 Jun; 67(6):2244-2256. PubMed ID: 34050852
[TBL] [Abstract][Full Text] [Related]
19. ANKHD1 promotes proliferation and invasion of non‑small‑cell lung cancer cells via regulating YAP oncoprotein expression and inactivating the Hippo pathway.
Liu XF; Han Q; Rong XZ; Yang M; Han YC; Yu JH; Lin XY
Int J Oncol; 2020 May; 56(5):1175-1185. PubMed ID: 32319569
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
[No Abstract] [Full Text] [Related]
[Next] [New Search]
